Charles Brenton Huggins

Facts

Charles Brenton Huggins

Charles Brenton Huggins

Born: 22 September 1901, Halifax, Canada

Died: 12 January 1997, Chicago, IL, USA

Affiliation at the time of the award: University of Chicago, Ben May Laboratory for Cancer Research, Chicago, IL, USA

Prize motivation: "for his discoveries concerning hormonal treatment of prostatic cancer."

Prize share: 1/2

Work

In cancer, cells grow and multiply beyond normal limits. Prostate cancer, which attacks a gland that is part of the male sex organ, is one of the more common forms of cancer. Around 1940 Charles Huggins showed that the course of the disease can be affected by hormones. If the production of male sex hormone is prevented through castration or if female sex hormone is added, the cancer could be counteracted. Hormone treatment for prostate cancer quickly gained traction. Charles Huggins also developed hormone treatment for breast cancer.

To cite this section
MLA style: Charles B. Huggins – Facts. NobelPrize.org. Nobel Media AB 2018. Mon. 20 Aug 2018. <https://www.nobelprize.org/prizes/medicine/1966/huggins/facts/>

Back to top Back To Top Takes users back to the top of the page

Explore prizes and laureates

Look for popular awards and laureates in different fields, and discover the history of the Nobel Prize.